Alder BioPharmaceuticals reports second quarter 2016 financial results
Alder reported $0.1 million of revenue under license agreement in the 2016 second quarter. Alder did not record any revenue in the second quarter of 2015. Net loss for the 2016 second quarter totaled $38.9 million versus a net loss of $17.7 million for the same period in 2015. July 26, 2016